Becton Dickinson (XSWX:BDX) Dividends Received


XSWX:BDX Becton Dickinson & Co XSWX:BDX
78 GF Score
Price CHF126.68
GF Value CHF153.95
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XSWX:BDX
78GF Score
Becton Dickinson & Co XSWX:BDX
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF126.68 is trading 17.7% below its estimated GF Value™ of CHF153.95.

Key valuation signals for XSWX:BDX:

  • Dividends Received:
  • GF Value™: CHF153.95 vs. price of CHF126.68 (17.7% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
78GF Score

Get the complete analysis for XSWX:BDX

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF126.68
Price
CHF153.95
GF Value